|
|
immune response
|
GO:0006955 |
307 |
0.912
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.911
|
|
|
|
regulation of intracellular transport of viral material
|
GO:1901252 |
2 |
0.822
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.776
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.773
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.684
|
|
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.626
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.597
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.595
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.595
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.576
|
Human Mouse |
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.576
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.567
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.495
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.485
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.465
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.456
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.435
|
Human |
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.433
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.367
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.352
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.350
|
Human |
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.344
|
Human |
|
|
activation of immune response
|
GO:0002253 |
114 |
0.341
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.340
|
Human |
|
|
negative regulation of viral transcription
|
GO:0032897 |
23 |
0.322
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.313
|
|
|
|
negative regulation of calcium ion import
|
GO:0090281 |
1 |
0.301
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.268
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.264
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.262
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.254
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.251
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.248
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.245
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.244
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.242
|
|
|
|
negative regulation of protein deubiquitination
|
GO:0090086 |
3 |
0.241
|
|
|
|
regulation of fas signaling pathway
|
GO:1902044 |
2 |
0.235
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.235
|
Human |
|
|
protein maturation
|
GO:0051604 |
233 |
0.233
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.228
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.226
|
Human |
|
|
entry into host
|
GO:0044409 |
25 |
0.206
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
62 |
0.195
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.189
|
Human |
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.185
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.185
|
Human |
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.183
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
18 |
0.181
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.175
|
Human |
|
|
positive regulation of interleukin 1 beta secretion
|
GO:0050718 |
11 |
0.174
|
Human |
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.173
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
35 |
0.168
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.167
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.166
|
Human |
|
|
fas signaling pathway
|
GO:0036337 |
3 |
0.161
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.160
|
Human |
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.159
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.157
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.156
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
66 |
0.154
|
|
|
|
viral gene expression
|
GO:0019080 |
35 |
0.153
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.149
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.148
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.144
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.142
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.141
|
Human |
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.139
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.138
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.136
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.134
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.134
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.133
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.132
|
|
|
|
interleukin 2 secretion
|
GO:0070970 |
3 |
0.131
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.130
|
Human |
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.127
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.126
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.124
|
Human |
|
|
actin nucleation
|
GO:0045010 |
21 |
0.122
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.122
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.118
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.118
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
21 |
0.118
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.117
|
|
|
|
negative regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000059 |
3 |
0.115
|
|
|
|
positive regulation of interleukin 1 production
|
GO:0032732 |
14 |
0.112
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.111
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.109
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
4 |
0.108
|
|
|
|
protein autoprocessing
|
GO:0016540 |
4 |
0.108
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.106
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.106
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.105
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.105
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.103
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.101
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.100
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.098
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.098
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.097
|
Human |
|
|
movement in host environment
|
GO:0052126 |
25 |
0.097
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.096
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.095
|
|
|
|
autophagic cell death
|
GO:0048102 |
3 |
0.094
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.094
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.093
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.091
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.091
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.090
|
Human |
|
|
viral transcription
|
GO:0019083 |
35 |
0.087
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.083
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.082
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.082
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.081
|
|
|
|
positive regulation of interleukin 1 beta production
|
GO:0032731 |
13 |
0.081
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.081
|
|
|
|
regulation of interleukin 1 beta secretion
|
GO:0050706 |
12 |
0.080
|
Human |
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.080
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.079
|
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.078
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.078
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.078
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.076
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.075
|
Human |
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.073
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
55 |
0.073
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.072
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.072
|
|
|
|
melanin metabolic process
|
GO:0006582 |
1 |
0.072
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.072
|
Human |
|
|
entry into other organism involved in symbiotic interaction
|
GO:0051828 |
25 |
0.071
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
45 |
0.070
|
Human |
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.070
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.069
|
|
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.069
|
|
|
|
negative regulation of intracellular transport of viral material
|
GO:1901253 |
2 |
0.069
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.067
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.066
|
|
|
|
viral genome replication
|
GO:0019079 |
50 |
0.066
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.064
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.064
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.064
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.062
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.062
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.061
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.061
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.061
|
Human |
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.060
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.060
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.060
|
Human |
|
|
vasculature development
|
GO:0001944 |
181 |
0.059
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.059
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.058
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.058
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.058
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.057
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.057
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.057
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.057
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.056
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.056
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.056
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.056
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.055
|
|
|
|
positive regulation of cell cycle arrest
|
GO:0071158 |
23 |
0.054
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.054
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.054
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.053
|
Mouse |
|
|
nuclear transport
|
GO:0051169 |
179 |
0.053
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.052
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.052
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
60 |
0.052
|
Human |
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.051
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.050
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.050
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.050
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.050
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.050
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.049
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.049
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.049
|
Human |
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.049
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.048
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.048
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.048
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.048
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.048
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.048
|
Human |
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.048
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.047
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.047
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.047
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.047
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.047
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.046
|
|
|
|
positive regulation of response to biotic stimulus
|
GO:0002833 |
18 |
0.046
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.045
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.045
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.044
|
Human |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.043
|
Human |
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.043
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.043
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.043
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.043
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
42 |
0.042
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.042
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.042
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.042
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.041
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.041
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.041
|
Human |
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.041
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.041
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.041
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
33 |
0.039
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.039
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.039
|
|
|
|
adaptive immune response
|
GO:0002250 |
49 |
0.039
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.039
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.039
|
|
|
|
regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031664 |
13 |
0.039
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.038
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.038
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.038
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.038
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.038
|
Human |
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.038
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.038
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.038
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.037
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.037
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.037
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
92 |
0.036
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.036
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.036
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.035
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.035
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.035
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.035
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.035
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.035
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.034
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.034
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.034
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.034
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.034
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.033
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.033
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.033
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.033
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.033
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
11 |
0.033
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.033
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.033
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.033
|
|
|
|
peptide metabolic process
|
GO:0006518 |
51 |
0.032
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.032
|
|
|
|
regulation of viral entry into host cell
|
GO:0046596 |
17 |
0.032
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.032
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.032
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.032
|
|
|
|
regulation of interleukin 1 secretion
|
GO:0050704 |
14 |
0.032
|
Human |
|
|
protein autoubiquitination
|
GO:0051865 |
37 |
0.032
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
67 |
0.032
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.031
|
|
|
|
positive regulation of protein polymerization
|
GO:0032273 |
45 |
0.031
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.031
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.030
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.030
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
26 |
0.030
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
60 |
0.030
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.030
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.030
|
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.029
|
Human |
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.029
|
|
|
|
interleukin 1 secretion
|
GO:0050701 |
18 |
0.029
|
Human |
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
45 |
0.029
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.029
|
|
|
|
viral entry into host cell
|
GO:0046718 |
24 |
0.029
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
48 |
0.029
|
|
|
|
positive regulation of humoral immune response
|
GO:0002922 |
3 |
0.029
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.028
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.028
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.028
|
Human |
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.028
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
15 |
0.028
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.028
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.028
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.028
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
37 |
0.028
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.027
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.027
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.027
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.027
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.027
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.027
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.026
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.026
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.026
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.026
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.026
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
56 |
0.026
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.026
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.026
|
Human Mouse |
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.026
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.026
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.025
|
|
|
|
intracellular transport of virus
|
GO:0075733 |
14 |
0.025
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.025
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.025
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.025
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.025
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.025
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.025
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.024
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
11 |
0.024
|
|
|
|
multi organism localization
|
GO:1902579 |
14 |
0.024
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.024
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.024
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.024
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.024
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.024
|
Human |
|
|
mating
|
GO:0007618 |
1 |
0.024
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
57 |
0.024
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.023
|
|
|
|
multi organism intracellular transport
|
GO:1902583 |
14 |
0.023
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001269 |
1 |
0.023
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.023
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.023
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.023
|
Human |
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
17 |
0.023
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.023
|
|
|
|
dna damage response signal transduction resulting in transcription
|
GO:0042772 |
12 |
0.023
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.023
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.023
|
Human |
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.023
|
|
|
|
aging
|
GO:0007568 |
66 |
0.022
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
83 |
0.022
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.022
|
Human |
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.022
|
|
|
|
alditol phosphate metabolic process
|
GO:0052646 |
3 |
0.022
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.022
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
2 |
0.022
|
|
|
|
negative regulation of interleukin 2 production
|
GO:0032703 |
7 |
0.022
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.022
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.022
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.022
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.022
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.021
|
|
|
|
negative regulation of protein secretion
|
GO:0050709 |
29 |
0.021
|
|
|
|
system process
|
GO:0003008 |
349 |
0.021
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.021
|
|
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
25 |
0.021
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.021
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.021
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.021
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.021
|
|
|
|
regulation of viral release from host cell
|
GO:1902186 |
20 |
0.021
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.021
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.021
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
81 |
0.021
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
83 |
0.021
|
|
|
|
regulation of protein polymerization
|
GO:0032271 |
63 |
0.021
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.021
|
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
38 |
0.021
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.020
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.020
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.020
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.020
|
Mouse |
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.020
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.020
|
|
|
|
regulation of defense response to virus by host
|
GO:0050691 |
22 |
0.020
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.020
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.020
|
Human |
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.020
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.020
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.020
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.020
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
33 |
0.020
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
76 |
0.020
|
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.019
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.019
|
|
|
|
regulation of autophagy
|
GO:0010506 |
52 |
0.019
|
|
|
|
membrane hyperpolarization
|
GO:0060081 |
1 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.019
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.019
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.019
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.019
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.019
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.019
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.019
|
|
|
|
regulation of protein deubiquitination
|
GO:0090085 |
4 |
0.019
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.019
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.018
|
|
|
|
actin filament polymerization
|
GO:0030041 |
45 |
0.018
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.018
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.018
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.018
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.018
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
51 |
0.018
|
Human |
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.018
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.017
|
|
|
|
positive regulation of interleukin 10 secretion
|
GO:2001181 |
2 |
0.017
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.017
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.017
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
42 |
0.017
|
Human |
|
|
cellular response to interferon gamma
|
GO:0071346 |
24 |
0.017
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.017
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.017
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
40 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.017
|
|
|
|
regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902041 |
24 |
0.017
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.017
|
Human |
|
|
growth
|
GO:0040007 |
202 |
0.017
|
|
|
|
cellular modified amino acid biosynthetic process
|
GO:0042398 |
15 |
0.017
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
10 |
0.017
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.016
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.016
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.016
|
|
|
|
humoral immune response
|
GO:0006959 |
49 |
0.016
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.016
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
1 |
0.016
|
|
|
|
calcium ion import
|
GO:0070509 |
23 |
0.016
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
9 |
0.016
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.016
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.016
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.016
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.016
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.016
|
|
|
|
viral release from host cell
|
GO:0019076 |
21 |
0.016
|
|
|
|
telomere maintenance
|
GO:0000723 |
32 |
0.016
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.016
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.016
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.016
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.016
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.015
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.015
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.015
|
|
|
|
protein export from nucleus
|
GO:0006611 |
29 |
0.015
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.015
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
48 |
0.015
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
20 |
0.015
|
|
|
|
negative regulation of epithelial cell migration
|
GO:0010633 |
38 |
0.015
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.015
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
21 |
0.015
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.015
|
|
|
|
respiratory system development
|
GO:0060541 |
22 |
0.015
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
39 |
0.015
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
38 |
0.015
|
Human |
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.015
|
|
|
|
secondary metabolic process
|
GO:0019748 |
17 |
0.015
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
13 |
0.014
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
37 |
0.014
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.014
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.014
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.014
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.014
|
|
|
|
amide biosynthetic process
|
GO:0043604 |
15 |
0.014
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.014
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.014
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.014
|
|
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
35 |
0.014
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
2 |
0.014
|
|
|
|
activation of innate immune response
|
GO:0002218 |
55 |
0.014
|
|
|
|
regulation of interferon gamma biosynthetic process
|
GO:0045072 |
8 |
0.014
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.014
|
|
|
|
protein deubiquitination
|
GO:0016579 |
79 |
0.014
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.014
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.014
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.014
|
|
|
|
toxin transport
|
GO:1901998 |
4 |
0.014
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.014
|
|
|
|
negative regulation of viral release from host cell
|
GO:1902187 |
12 |
0.014
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.013
|
|
|
|
neuron remodeling
|
GO:0016322 |
2 |
0.013
|
|
|
|
protein polymerization
|
GO:0051258 |
71 |
0.013
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.013
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
56 |
0.013
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.013
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.013
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.013
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.013
|
|
|
|
midgut development
|
GO:0007494 |
1 |
0.013
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.013
|
Mouse |
